175 related articles for article (PubMed ID: 22034878)
21. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
23. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
24. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
[TBL] [Abstract][Full Text] [Related]
25. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
26. Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone.
Lan J; Liu X; Rong W; Wei F; Jiang L; Yu H; Dang G; Liu Z
J Surg Oncol; 2012 Dec; 106(7):826-36. PubMed ID: 22605660
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: a study on the nature of stromal and giant cells, and their interrelations.
Hasegawa T; Hirose T; Seki K; Sano T; Hizawa K
J Pathol; 1993 Jul; 170(3):305-10. PubMed ID: 7907656
[TBL] [Abstract][Full Text] [Related]
28. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C
Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014
[TBL] [Abstract][Full Text] [Related]
29. CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression.
Ng PK; Tsui SK; Lau CP; Wong CH; Wong WH; Huang L; Kumta SM
J Cell Biochem; 2010 May; 110(2):438-46. PubMed ID: 20225273
[TBL] [Abstract][Full Text] [Related]
30. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
31. Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis.
Bovée JV; van den Broek LJ; de Boer WI; Hogendoorn PC
J Pathol; 1998 Jan; 184(1):24-30. PubMed ID: 9582523
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
33. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
[TBL] [Abstract][Full Text] [Related]
34. Analysis of giant cell tumour of bone cells for Noonan syndrome/cherubism-related mutations.
Moskovszky L; Idowu B; Taylor R; Mertens F; Athanasou N; Flanagan A
J Oral Pathol Med; 2013 Jan; 42(1):95-8. PubMed ID: 22725657
[TBL] [Abstract][Full Text] [Related]
35. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
[TBL] [Abstract][Full Text] [Related]
36. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
37. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
Noh BJ; Park YK
Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
[TBL] [Abstract][Full Text] [Related]
38. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
39. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone.
Forsyth RG; De Boeck G; Baelde JJ; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC
J Bone Miner Res; 2009 Jan; 24(1):70-7. PubMed ID: 18767926
[TBL] [Abstract][Full Text] [Related]
40. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
